NDC 0115-1488 – Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate

Dextroamphetamine Saccharate 3.75 mg/1; Amphetamine Aspartate Monohydrate 3.75 mg/1; Dextroamphetamine Sulfate 3.75 mg/1; Amphetamine Sulfate 3.75 mg/1 · Capsule · Oral

Human Prescription Drug DEA schedule CII

Product NDC0115-1488

Product details

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Generic name
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Labeler
Amneal Pharmaceuticals of New York LLC
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA076852
Marketed since
February 16, 2016
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate →

Package NDC codes (1)

Package NDCDescriptionSince
0115-1488-01100 CAPSULE in 1 BOTTLE (0115-1488-01)Feb 16, 2016

Other Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate products